tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tarsus Pharmaceuticals initiated with an Outperform at Mizuho
PremiumThe FlyTarsus Pharmaceuticals initiated with an Outperform at Mizuho
3M ago
Tarsus Pharmaceuticals price target raised to $51 from $45 at Goldman Sachs
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $51 from $45 at Goldman Sachs
4M ago
Tarsus Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Tarsus Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
4M ago
Tarsus Pharmaceuticals reports Q3 EPS (30c), consensus (33c)
PremiumThe FlyTarsus Pharmaceuticals reports Q3 EPS (30c), consensus (33c)
4M ago
TARS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
TARS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Promising Growth and Market Penetration of XDEMVY Drives Buy Rating and Increased Price Target
Premium
Ratings
Promising Growth and Market Penetration of XDEMVY Drives Buy Rating and Increased Price Target
4M ago
Tarsus Pharmaceuticals: Strong Market Performance and Strategic Growth Drive Buy Rating
PremiumRatingsTarsus Pharmaceuticals: Strong Market Performance and Strategic Growth Drive Buy Rating
7M ago
Tarsus Pharmaceuticals Reports Record Sales Growth
Premium
Company Announcements
Tarsus Pharmaceuticals Reports Record Sales Growth
7M ago
Tarsus Pharmaceuticals reports Q2 EPS (48c), consensus (36c)
Premium
The Fly
Tarsus Pharmaceuticals reports Q2 EPS (48c), consensus (36c)
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100